156 related articles for article (PubMed ID: 36259602)
1. Downregulation of desmoglein 2 promotes EMT progression in gallbladder cancer.
Wang L; Lv Y; Li J; Nan Y; Piao L; Liang Z
Histol Histopathol; 2023 Apr; 38(4):467-474. PubMed ID: 36259602
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
[TBL] [Abstract][Full Text] [Related]
3. [Kindlin-2 promotes gallbladder cancer metastasis and invasion by inducing epithelial-mesenchymal transition].
Lu X; Zhou C; Li RF; Ye JW; Zhai WL
Zhonghua Wai Ke Za Zhi; 2018 Aug; 56(8):617-622. PubMed ID: 30107706
[No Abstract] [Full Text] [Related]
4. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2.
Shen H; Zhan M; Zhang Y; Huang S; Xu S; Huang X; He M; Yao Y; Man M; Wang J
Cell Death Dis; 2018 Jan; 9(2):71. PubMed ID: 29358655
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC.
Xu G; Wei X; Tu Q; Zhou C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31799620
[TBL] [Abstract][Full Text] [Related]
6. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
[TBL] [Abstract][Full Text] [Related]
7. FOXA2 suppresses gallbladder carcinoma cell migration, invasion, and epithelial-mesenchymal transition by targeting SERPINB5.
Hong L; Chen M; Huang M; Chen W; Abudukeremu X; She F; Chen Y
Environ Toxicol; 2024 Feb; 39(2):708-722. PubMed ID: 37665156
[TBL] [Abstract][Full Text] [Related]
8. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
[TBL] [Abstract][Full Text] [Related]
9. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
[TBL] [Abstract][Full Text] [Related]
10. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
11.
Liu Z; Jin H; Yang S; Cao H; Zhang Z; Wen B; Zhou S
J Int Med Res; 2020 Aug; 48(8):300060520947883. PubMed ID: 32812461
[TBL] [Abstract][Full Text] [Related]
12. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
[TBL] [Abstract][Full Text] [Related]
13. Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation.
Lee SH; Kim JM; Lee DG; Lee J; Park JG; Han TS; Cho HS; Cho YL; Bae KH; Park YJ; Lee SJ; Lee MS; Huh YM; Jo DY; Yun HJ; Jeon HJ; Kim N; Joo M; Kim JS; Lee HJ; Min JK
Cell Death Differ; 2021 Mar; 28(3):968-984. PubMed ID: 32989241
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA Linc-ITGB1 knockdown inhibits cell migration and invasion in GBC-SD/M and GBC-SD gallbladder cancer cell lines.
Wang L; Zhang Y; Lv W; Lu J; Mu J; Liu Y; Dong P
Chem Biol Drug Des; 2015 Nov; 86(5):1064-71. PubMed ID: 25893892
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW
Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA.
Yan J; Dai P; Qin X; He Y; Zhang Y
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913073
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-6 is associated with epithelial-mesenchymal transition and survival rates in gallbladder cancer.
Zhang M; Gong W; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Jiang A; Ma F; Quan Z
Mol Med Rep; 2015 May; 11(5):3539-46. PubMed ID: 25573292
[TBL] [Abstract][Full Text] [Related]
18. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182
[TBL] [Abstract][Full Text] [Related]
19. The microRNA cluster miR-214/miR-3120 prevents tumor cell switching from an epithelial to a mesenchymal-like phenotype and inhibits autophagy in gallbladder cancer.
Li W; Yan P; Meng X; Zhang J; Yang Y
Cell Signal; 2021 Apr; 80():109887. PubMed ID: 33340658
[TBL] [Abstract][Full Text] [Related]
20. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J
Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
